Company Search:
Advanced Search
Sponsored Links
Epirus Biopharmaceuticals Inc Company Snapshot
Epirus Biopharmaceuticals Inc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Epirus Biopharmaceuticals Inc with three other companies in this sector in UNITED STATES : Innovus Pharmaceuticals Inc (2015 sales of $735,717.00 ), Genocea Biosciences Inc ($670,000.00 of which 100% was Discovers and Develops Novel Vaccines), and Adhera Therapeutics Inc ($680,000.00 ).

Sales Analysis. Sales increased substantially in 2015: During the year ended December of 2015, sales at Epirus Biopharmaceuticals Inc were $701,000.00 . This is an increase of 17,425.0% versus 2014, when the company's sales were $4,000.00 . Despite this increase, sales are still well below the level achieved in 2013, when Epirus Biopharmaceuticals Inc reported sales of $14.73 million.
  Stock Performance Chart for Epirus Biopharmaceuticals Inc
  Stock Data: Recent Stock Performance:
  Current Price (2/19/2021): .04
(Figures in U.S. Dollars)
1 Week 93.8%   13 Weeks 265.8%  
4 Weeks 1,363.3%   52 Weeks 4,777.8%  
Epirus Biopharmaceuticals Inc Key Data:
  Ticker: EPRSQ Country: United States
  Exchanges: NAS FRA Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 701,000
(Year Ending Jan 2016).
Employees: 46
  Currency: U.S. Dollars Market Cap: 1,149,493
  Fiscal Yr Ends: December Shares Outstanding: 26,184,349
  Share Type: Common Closely Held Shares:
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.